Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
01/29/15 10-K/A Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 15
01/29/15 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 101
04/16/14 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
EX-31
EX-31
EX-32
EX-32
HTML PDF 41
01/17/14 10-K/A Annual report pursuant to section 13 and 15(d) HTML PDF XBRL Viewer XLS XBRL Files 6
01/16/14 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-3
EX-21
EX-23
EX-31
EX-31
EX-32
EX-32
HTML PDF 111
08/27/13 ARS Annual report to security holders HTML PDF 108
01/29/13 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-3
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-23
EX-31
EX-31
EX-32
EX-32
HTML PDF XBRL Viewer XLS XBRL Files 244
01/30/12 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 94
02/14/11 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.26
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 102
01/31/11 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT HTML PDF 4
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next >>

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Dec 19, 2022

Anixa Biosciences to Present at Biotech Showcase 2023

Read More...
Dec 8, 2022

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine

Read More...
Nov 8, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium

Read More...
Copyrights © 2023 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap